Pink SheetA single-arm study cannot provide interpretable results supporting promotional claims for progression-free survival or overall survival, the US Food and Drug Administration said in an advertising and
Pink SheetPharmaceutical companies are learning to navigate the US Food and Drug Administration’s final rule on presentation of the major statement in direct-to-consumer TV ads in a clear, conspicuous and neutr
Pink SheetA celebrity influencer’s Instagram post for Merz Pharma ’s Xeomin (incobotulinumtoxinA) minimized the drug’s serious risks and suggested faster efficacy than demonstrated in clinical trials, the US F
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License